This suggests that the increased frequency of CXCL13+Texp in NSCLC post anti-PD-1 results from decreased pressure within the TME on newly infiltrating tumour reactive T cells to progress towards terminal differentiation upon stimulation, rather than phenotypic change in existing exhausted T cells. This evidence concerns the gene CXCL13 and non-small cell lung carcinoma.